MedPath

A Comparative Study on the Efficacy of AI Temperature-controlled Radiofrequency Technology and Electrical Stimulation in the Treatment of Vulvar Leukoplakia

Not Applicable
Recruiting
Conditions
Vulvar Lichen Sclerosus
Interventions
Procedure: Radiofrequency technology
Procedure: Electrical stimulation
Registration Number
NCT05250466
Lead Sponsor
Zhongnan Hospital
Brief Summary

The study was designed as a prospective, multicenter, randomized, open-label, parallel-controlled clinical trial. The study population was patients with vulvar leukoplakia, and compared the efficacy and safety of AI temperature-controlled radio frequency technology and electrical stimulation in the treatment of vulvar leukoplakia. According to the research purpose, the sample size was calculated and determined to be 120 cases, and they were randomly assigned to the observation group and the control group according to the ratio of 1:1, namely 60 cases in the radio frequency observation group and 60 cases in the electric stimulation control group.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
120
Inclusion Criteria
  1. Diagnosed by pathological examination, meeting the diagnostic criteria for leukoplakia;
  2. 18 to 60 years old;
  3. Agree to sign the informed consent;
Exclusion Criteria
  1. Patients with severe liver and kidney dysfunction;
  2. Combined with HIV, syphilis infection, acute vaginitis, cervical cancer;
  3. Patients with cardiovascular disease;
  4. People with hematological diseases;
  5. Patients with hypertension and diabetes;
  6. People with mental illness;
  7. Pregnant and lactating women.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Radiofrequency groupRadiofrequency technologyAI Temperature-controlled Radiofrequency Technology
Electrical stimulation groupElectrical stimulationElectrical Stimulation
Primary Outcome Measures
NameTimeMethod
Efficacy index6 month after treatment

Efficacy index: (score before treatment-score after treatment)/(score before treatment)×100%

Secondary Outcome Measures
NameTimeMethod
Recurrence rate6 month after treatment

Percentage of recurrence of genital itching 6 months after treatment

Trial Locations

Locations (1)

Zhongnan Hospital of Wuhan University

🇨🇳

Wuhan, Hubei, China

© Copyright 2025. All Rights Reserved by MedPath